
Defining the Contemporary High-Risk PCI Patient
The FDA has granted Impella its highest level of approval as a safe and effective therapy for high-risk PCI, cardiogenic shock and right heart failure.
- 1,200+
Peer-reviewed clinical studies have published on Impella, including the PROTECT II randomized controlled trial
- 13
Clinical society guidelines include Impella heart pumps
- 250,000+
Patients have been treated with Impella heart pumps
Echocardiography Views and Color Doppler for Impella
Michael Galvin, RDCS, a cardiac sonographer and Abiomed Clinical Support Center specialist, describes the four major views that make up a full echocardiogram as well as the role of color and spectral Doppler in assessing Impella position.

For Interventional Cardiologists
Treat high-risk PCI, cardiogenic shock and right heart failure patients

For Cardiac and Vascular Surgeons
Escalate, stabilize and recover native organs with minimally-invasive surgical techniques

For Nurses
Use calculators, watch quick skills videos and learn patient management best practices

For Fellows
Advance your knowledge and develop skills to treat complex PCI patients

For Referring Providers
Are you caring for patients with heart disease? Learn more about how Impella heart pumps work, the benefits of Protected PCI with Impella and explore patient identification resources.
NPS-1309